Dr. Wang received his MD from the Harvard-MIT Health Sciences and Technology Program at Harvard Medical School. He then obtained his clinical training from the Harvard Radiation Oncology Program. During residency, Dr. Wang also completed a postdoctoral research fellowship at MIT under the mentorship of Dr. Robert Langer. Dr. Wang first joined the faculty at University of North Carolina Chapel Hill in 2009 and rose to the rank of tenured full professor in 2020. He joined UTSW in 2021 as Vice Chair of Clinical and Translational research in the department of radiation oncology. He also holds the A. Kenneth Pye Professorship in Cancer Research. As a physician scientist, Dr. Wang’s research program is focused on the application of biomedical engineering and chemical engineering to improve disease treatment. His research spans a wide spectrum of translational research, from preclinical research to early phase clinical trials. His research has been supported by grants from the NIH/NCI, Department of Defense, foundations and industry. Dr. Wang has received numerous awards such as Fellow of American Association for the Advancement of Science (AAAS) and The American Institute for Medical and Biological Engineering (AIMBE) . He has cofounded 2 biotech startup companies. He is on the editorial Boards of Journal of the National Cancer Institute, Nanomedicine NBM and WIRES Nano.